The first helicobacter pylori screen-and-treat population-based study in young adults in europe
Background Most gastric cancer cases are attributable to chronic Helicobacter pylori (H. pylori) infection and can theoretically be prevented. Objective In the EUROHELICAN project, we aimed to assess the feasibility, acceptability, effectiveness, and adverse events of a Helicobacter pylori screen-and-treat program in the 30–34-year age group for the first time in Europe. Design The study was conducted in the Community Healthcare Center dr. Adolf Drolc Maribor, following the methodology prepared by the National Institute of Public Health. We invited asymptomatic individuals aged 30–34 to be tested for H. pylori IgG antibodies
Authors
- Mitja Oblak
- Jernej Završnik (ORCID: https://orcid.org/0000-0002-5023-0483)
- Alja Polajžer
- Marcel Kralj (ORCID: https://orcid.org/0009-0009-4107-0797)
- Helena Blažun Vošner
- Nataša Maguša Lorber
- Tatjana Kofol-Bric
- Bojan Tepeš
- Jin Young Park
- Tamara Matysiak‐Budnik
Institutions
- Zdravstveni dom dr. Adolfa Drolca Maribor (SI)
- National Institute of Public Health (SI)
- University Clinical Centre Maribor (SI)
- Rogaška Medical Centre (SI)
- Centre international de recherche sur le cancer (FR)
Publication Details
- Journal
- DiRROS repository (University of Maribor)
- Published
- 2026-02-26
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00